Clinical Trial

EndoForce Post Approval Study

Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to collect long-term safety and performance data for the use of the EndoForce System for connecting a hemodialysis graft to a vein in patients with End Stage Renal Disease. This is not an experimental procedure or an experimental therapy. This means that the study device has been approved by the FDA.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-08-21; most recent amendment 2026-01-16.
Status change: Not Yet Recruiting → Recruiting 2026-01-16
Trial Details
NCT Number NCT07146854
Lead Sponsor Phraxis, Inc.
Conditions End Stage Renal Disease (ESRD)
Enrollment 150 participants
Start Date 2026-01-13
Primary Completion 2029-12 (estimated)
Study Completion 2029-12 (estimated)
Updated on ClinicalTrials.gov 2026-01-21